Oncology Society of Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2021 edition).
10.3760/cma.j.cn112152-20210207-00118
- VernacularTitle:中华医学会肿瘤学分会肺癌临床诊疗指南(2021版)
- Collective Name:Oncology Society of Chinese Medical Association;Chinese Medical Association Publishing House
- Publication Type:Journal Article
- Keywords:
Diagnosis;
Guideline;
Lung neoplasms;
Therapy
- MeSH:
China;
Consensus;
Early Detection of Cancer;
Humans;
Lung Neoplasms/therapy*;
Medical Oncology
- From:
Chinese Journal of Oncology
2021;43(6):591-621
- CountryChina
- Language:Chinese
-
Abstract:
In China, the incidence and mortality of lung cancer are ranked the first among malignant tumors. In order to further standardize the prevention and treatment measures of lung cancer, improve the prognosis of patients, and provide professional evidence-based medical recommendations to clinical medical staffs, Oncology Society of Chinese Medical Association organized experts from departments of pulmonary medicine, oncology, thoracic surgery, radiotherapy, imaging and pathology, based on the international guidelines and clinical practices in China, integrated the latest evidence-based medical evidences in lung cancer pathology, genetic testing, immune molecular marker detection and treatment methods in recent years. After consensus meetings, the Oncology Society of Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer in China was conducted, which provided recommendations of lung cancer screening, diagnosis, pathology, treatment and follow-up to clinicians, imaging, laboratory, and rehabilitation professionals.
